FIELD: molecular biology; medicine.
SUBSTANCE: invention refers to molecular biology, medicine, particularly to infectious diseases. Disclosed is a method for predicting the severity of EBV-associated infectious mononucleosis (IM), characterized by the fact that peripheral blood leukocytes in patients with EBV-associated infectious mononucleosis are characterized by mRNA expression FPGS.NM_00018078 and PCNA.NM_002592 and if the levels of their expression are higher than that of healthy donors, a moderate-to-severe condition is predicted, while a lower one shows a severe clinical course of the disease.
EFFECT: invention provides prediction of EBV-IM course that promotes timely adequate antiviral and immunomodulatory therapy.
1 cl, 1 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| DIAGNOSTIC TECHNIQUE FOR SEVERE FORM OF THE EBV-ASSOCIATED INFECTIOUS MONONUCLEOSIS | 2020 |
|
RU2732012C1 |
| METHOD FOR DIFFERENTIAL DIAGNOSIS OF HERPES VIRUS MIXED INFECTION | 2020 |
|
RU2739854C1 |
| METHOD FOR DIFFERENTIAL DIAGNOSIS OF INFECTIOUS MONONUCLEOSIS OF VARIOUS AETIOLOGY | 2019 |
|
RU2707077C1 |
| BIOMARKERS OF DEVELOPING COMPLICATIONS OF INFECTIOUS MONONUCLEOSIS ASSOCIATED WITH EPSTEIN-BARR VIRUS | 2019 |
|
RU2720110C1 |
| METHOD FOR IDENTIFYING INFECTIOUS MONONUCLEOSIS ASSOCIATED WITH EPSTEIN-BARR VIRUS | 2019 |
|
RU2732813C1 |
| METHOD FOR PREDICTION OF THE RISK OF DEVELOPING WEB-ASSOCIATED TUMORS IN THE PATIENTS WITH ACUTE EBV-INFECTION | 2019 |
|
RU2707075C1 |
| METHOD OF DIFFERENTIAL EXPRESS DIAGNOSTICS OF ACUTE VIRAL AND BACTERIAL INFECTIONS | 2015 |
|
RU2602677C1 |
| METHOD FOR IDENTIFYING INFECTIOUS MONONUCLEOSIS ASSOCIATED WITH TYPE 6 HUMAN HERPES VIRUS | 2019 |
|
RU2729413C1 |
| METHOD FOR DIAGNOSING THE SEVERITY OF EPSTEIN-BARR VIRUS-INDUCED ACUTE INFECTIOUS MONONUCLEOSIS IN CHILDREN | 2022 |
|
RU2797960C1 |
| METHOD OF FORECASTING SERIOUSNESS OF INFECTIOUS MONONUCLEOSIS OF VARIOUS ETIOLOGY AT CHILDREN | 2008 |
|
RU2360255C1 |
